United States of America
3 Vaccines Approved for Use in United States of America
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Approval Source: nytimes.com
RNA
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: nytimes.com
42 in Clinical Trials in United States of America
Protein Subunit
Novavax
Nuvaxovid
Approved in 37 countries
16 trials in 12 countries
Protein Subunit
COVAXX
UB-612
7 trials in 2 countries
Protein Subunit
Sanofi/GSK
Recombinant Protein
6 trials in 7 countries
VLP
Medicago
Covifenz
Approved in 1 country
6 trials in 6 countries
DNA
Inovio
INO-4800
9 trials in 9 countries
RNA
Arcturus Therapeutics Inc
ARCT-154
6 trials in 3 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
RNA
Pfizer/BioNTech
BNT162b2s01
3 trials in 2 countries
RNA
Pfizer/BioNTech
BNT162b1
5 trials in 3 countries
RNA
Moderna
mRNA-1273.617.2
2 trials in 1 country
RNA
Moderna
Spikevax
Approved in 86 countries
67 trials in 23 countries
RNA
Moderna
mRNA-1273.213
2 trials in 1 country
RNA
Moderna
mRNA-1273.211
4 trials in 1 country
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Inactivated
Bharat Biotech
Covaxin
Approved in 14 countries
14 trials in 2 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
30 trials in 12 countries
Protein Subunit
Kentucky Bioprocessing
KBP-201
2 trials in 1 country
RNA
Arcturus Therapeutics Inc
ARCT-165
2 trials in 2 countries
RNA
Arcturus Therapeutics Inc
LUNAR-COV19/ARCT-021
6 trials in 2 countries
RNA
Moderna
mRNA-1283
2 trials in 1 country
RNA
Moderna
mRNA-1283.211
RNA
Pfizer/BioNTech
BNT162b2 (B.1.1.7 + B.1.617.2)
RNA
Pfizer/BioNTech
BNT162b2 (B.1.1.7)
RNA
Pfizer/BioNTech
BNT162b2 (B.1.617.2)
Non Replicating Viral Vector
ImmunityBio Inc
hAd5-Covid-19
7 trials in 2 countries
Non Replicating Viral Vector
Mahidol University
NDV-HXP-S
7 trials in 3 countries
Non Replicating Viral Vector
Vaxart
VXA-CoV2-1.1-S
Replicating Viral Vector
Aivita Biomedical Inc
AV-COVID-19
4 trials in 2 countries
Replicating Viral Vector
City of Hope Medical Center
COH04S1
2 trials in 1 country
Protein Subunit
US Army Medical Research and Development Command
SpFN COVID-19 Vaccine
DNA
Providence Health & Services
CORVax12
RNA
GlaxoSmithKline
CoV2 SAM (LNP)
RNA
GlaxoSmithKline
CV2CoV
RNA
HDT Bio
HDT-301
RNA
Moderna
mRNA-1273.351
Non Replicating Viral Vector
CyanVac LLC
CVXGA1
Non Replicating Viral Vector
NIAID
ChAdV68-S
Non Replicating Viral Vector
NIAID
SAM-LNP-S
Non Replicating Viral Vector
Vaxart
VXA-CoV2-1
Replicating Viral Vector
Meissa Vaccines Inc
MV-014-212
RNA
Moderna
mRNA-1073
2 trials in 1 country
4 Vaccines with Trials in United States of America are No Longer Progressing
Non Replicating Viral Vector
Altimmune Inc
AdCOVID
Replicating Viral Vector
Merck Sharp & Dohme Corp
V590
Replicating Viral Vector
Merck Sharp & Dohme Corp
V591
2 trials in 3 countries
RNA
Sanofi Pasteur
MRT5500
2 trials in 1 country